Intuitive Surgical, Inc. (NASDAQ:ISRG) Stake Increased by LVW Advisors LLC

LVW Advisors LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,448 shares of the medical equipment provider’s stock after purchasing an additional 19 shares during the period. LVW Advisors LLC’s holdings in Intuitive Surgical were worth $756,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Godsey & Gibb Inc. lifted its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares in the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter valued at $33,000. Decker Retirement Planning Inc. purchased a new stake in shares of Intuitive Surgical in the fourth quarter valued at $36,000. Capital Performance Advisors LLP purchased a new stake in shares of Intuitive Surgical during the third quarter worth $38,000. Finally, DT Investment Partners LLC raised its holdings in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. Citigroup increased their price objective on Intuitive Surgical from $567.00 to $640.00 and gave the stock a “buy” rating in a report on Wednesday, December 11th. Robert W. Baird increased their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a report on Thursday, October 17th. Wells Fargo & Company increased their price objective on Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, December 11th. Finally, Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $592.64 on Monday. The company has a market cap of $211.09 billion, a P/E ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. The stock’s 50-day moving average is $540.66 and its 200-day moving average is $499.19. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Buying and Selling

In related news, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction dated Tuesday, December 10th. The stock was sold at an average price of $540.15, for a total value of $145,840.50. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock valued at $25,012,927 over the last three months. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.